Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Standard Biotools (LAB) Return on Invested Capital (2016 - 2025)

Standard Biotools (LAB) has disclosed Return on Invested Capital for 15 consecutive years, with 0.38% as the latest value for Q3 2025.

  • On a quarterly basis, Return on Invested Capital fell 8.0% to 0.38% in Q3 2025 year-over-year; TTM through Sep 2025 was 0.38%, a 8.0% decrease, with the full-year FY2024 number at 0.93%, down 234.0% from a year prior.
  • Return on Invested Capital was 0.38% for Q3 2025 at Standard Biotools, down from 0.35% in the prior quarter.
  • In the past five years, Return on Invested Capital ranged from a high of 12.3% in Q2 2022 to a low of 1.25% in Q1 2022.
  • A 5-year average of 0.83% and a median of 0.35% in 2025 define the central range for Return on Invested Capital.
  • Peak YoY movement for Return on Invested Capital: skyrocketed 1280bps in 2022, then tumbled -1105bps in 2023.
  • Standard Biotools' Return on Invested Capital stood at 0.65% in 2021, then skyrocketed by 490bps to 2.52% in 2022, then plummeted by -72bps to 0.71% in 2023, then tumbled by -159bps to 0.42% in 2024, then grew by 8bps to 0.38% in 2025.
  • Per Business Quant, the three most recent readings for LAB's Return on Invested Capital are 0.38% (Q3 2025), 0.35% (Q2 2025), and 0.4% (Q1 2025).